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 
Abstract— The paper describes strategies towards model-
based automation of intravenous anaesthesia employing 
advanced control techniques. In particular, based on a detailed 
compartmental mathematical model featuring pharmacokinetic 
and pharmacodynamics information two alternative model 
predictive control strategies are presented: a model predictive 
control strategy, based on online optimisation, the Extended 
Predictive Self Adaptive Control (EPSAC) and a multi-
parametric control strategy based on offline optimisation, the 
multi-parametric model predictive control (mp-MPC). The 
multi-parametric features to account for the effect of nonlinearity 
and the impact of estimation are also described. The control 
strategies are tested on a set of 12 virtually generated patient 
models for the regulation of the depth of anaesthesia (DOA) by 
means of the Bispectral Index (BIS) using Propofol as the 
administrated anaestetic. The simulations show fast response, 
suitability of dose and robustness to induce and maintain the 
desired BIS setpoint. 
 
Index Terms—Anaesthesia, inter-patient variability, MPC, 
EPSAC, mp-MPC, estimation  
I. INTRODUCTION 
NAESTHESIA plays a very important role in surgery and in 
the intensive care unit. It is defined as a reversible 
pharmacological state of the patient where hypnosis, 
analgesia and muscle relaxation are guaranteed [1]. Analgesics 
block the sensation of pain; hypnotics produce 
unconsciousness, while muscle relaxants prevent unwanted 
movement of muscle tone. 
The role of the anaesthetist has become more complex and 
indispensable to maintain the patients’ vital functions before, 
during and after surgery. To estimate the drug effect in the 
patient’s body and calculate the corresponding drug infusion 
rates average population models are used. These strategies 
may not always be safe for the patient since they do not take 
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into account any measured variable in a feedback control 
scheme and even if they reach the desired level of sedation 
fast, it can result in unsafe minimal values (undershoot) [1]. In 
stress situations the anaesthetist has to deal with routine 
assessments and simultaneously solve complex problems 
quickly. The automation of some routine actions of the 
anaesthetist can reduce the workload and consequently 
increase the safety of the patient. 
 The control of anaesthesia poses a manifold of challenges: 
inter- and intra-patient variability, multivariable 
characteristics, variable time delays, dynamics dependent on 
the hypnotic agent, model analysis variability, agent and 
stability issues [2], [3]. Hitherto, many PID tuning techniques 
have been elaborated. Since these classical controllers have no 
prior knowledge of the drug metabolism they cannot anticipate 
the response of the patient and their performance may be sub-
optimal. Other authors developed model based strategies using 
fuzzy [4], predictive [5], [6], [7], robust [8], [9], adaptive [2], 
[10] and multi-parametric MPC [11] control algorithms and 
applied them in clinical trials. 
 Drugs given for the induction and maintenance of DOA can 
be either inhalational or intravenous anaesthetics. An 
individualised physiological based, patient specific, 
compartmental model for volatile anaesthesia is presented and 
developed in [12] and a combined strategy of model predictive 
control (MPC) and estimation under uncertainty is presented 
in [13]. For intravenous anaesthesia, robustness tests of MPC 
for DOA using the EPSAC for a single input single output 
(SISO) model is presented in [14] , different protocols for the 
administration of Propofol and Remifentanil (multiple input 
single output (MISO) model) are evaluated in [15] and in [16] 
a second output variable is determined, that originates from 
the effect of Remifetanil and leads to the implementation of a 
MIMO algorithm. 
MPC is a model-based control technique that calculates the 
optimal control action considering constraints on the input, 
output and state variables by solving an optimization problem. 
The downside of this control technique is that the optimization 
problem has to be solved online. One way to avoid this is to 
use explicit/multi-parametric MPC which solves offline the 
optimization problem using multi-parametric programming 
and derives the control inputs as a set of explicit functions of 
the system states. An important advantage of mp-MPC is that 
the previously offline computed control laws can be easily 
implemented on embedded controllers. These types of devices 
use programming languages that cannot support powerful 
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mathematical computations. The optimal control laws are 
retrievable immediately through simple function evaluations. 
The aim of this paper is to design and compare four 
different types of model based controllers for administration 
of Propofol during ICU (Intensive Care Unit) sedation. Based 
on a compartmental pharmacokinetic (PK) and 
pharmacodynamic (PD) patient model, a predictive controller 
is first designed using an Extended Predictive Self Adaptive 
(EPSAC) strategy and three predictive controllers are designed 
using a mp-MPC strategy. The difference between the three 
controllers based on mp-MPC strategy is that one of them uses 
the linearized patient model whereas the other two use the 
compensation of the nonlinear part of the patient model. In 
one of the two controllers using the nonlinear compensation, 
the states are estimated using an online estimator, whilst for 
the other one the states are computed using the nominal 
patient model. 
The paper is organized as follows: the patient model, the 
multi-parametric control strategy, the EPSAC strategy and the 
design of the controllers are presented in the following section. 
Section 3 presents the simulation results for the induction and 
maintenance phase and discussions are presented in Section 4.  
Finally Section 5 summarizes the main outcome of this paper.  
II. THEORETICAL BACKGROUND 
A. Patient Model 
A compartmental model is used to describe the 
pharmacokinetic (PK) – pharmacodynamic (PD) blocks 
representing the distribution of drugs in the body, i.e. mass 
balance. The pharmacokinetic model represents the relation 
between the drug administration and drug concentration in the 
body, whereas the PD model represents the relation between 
the concentration of the drug in the central compartment and 
the effect observed on the patient. In each compartment the 
drug concentration is assumed to be uniform, as perfect and 
instantaneous mixing is assumed. The structure of the 
compartmental model is depicted in Fig. 1 [17], [18] .[10, 14]  
 
Fig. 1.  Compartmental model of the patient, where PK denotes the 
pharmacokinetic model and PD denotes the pharmacodynamic model. 
The PK-PD models most commonly used for Propofol are 
the 4
th
 order compartmental model described by Schnider [18], 
[19] and Minto [20], [21], respectively. These models, 
developed, tested and validated on a wide range of real patient 
data are commonly used in literature for the control of 
anaesthesia. 
PK describes the distribution of the drug in the human 
body. The PK model and the first term of the PD model are 
considered linear studied on real patient data with the 
collaboration of anaesthesiologists and validated using blood 
samples provided by hospitals. [18, 19, 22]: 
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where 1x represents the drug concentration in the central 
compartment [mg/l]. The peripheral compartments 2 (muscle) 
and 3 (fat) model the drug exchange of the blood with well 
and poorly diffused body tissues. The concentrations of drug 
in the fast and slow equilibrating peripheral compartments are 
denoted by x2 and x3 respectively. The parameters kij for i≠j, 
denote the drug transfer frequency from the i
th
 to the j
th 
compartment and u(t) [mg/min] is the infusion rate of the 
anaesthetic or analgesic  drug into the central compartment. 
The parameters kij of the PK models depend on age, weight, 
height and gender and can be calculated for Propofol: 
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where Cl1 is the rate at which the drug is cleared from the 
body, and Cl2 and Cl3 are the rates at which the drug is 
removed from the central compartment to the other two 
compartments by distribution.  
The lean body mass (lbm) for men (m) and women (f) are 
calculated by: 
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An additional hypothetical effect compartment is added to 
represent the lag between plasma drug concentration and drug 
response. The drug concentration in this compartment is 
represented by xe, called the effect-site compartment 
concentration. The effect compartment receives drug from the 
central compartment by a first-order process and it is 
considered as a virtual additional compartment. Therefore, the 
drug transfer frequency for Propofol from the central 
compartment to the effect site-compartment is considered in 
clinical practice to be equal to the frequency of drug removal 
from the effect-site compartment ke0=k1e=0.456 [min
-1
] [18], 
[19], [23]. When considering the drug effect observed on the 
patient, the BIS variable can be related to the effect drug 
concentration Ce by the empirical static nonlinear relationship 
[5], [6], [18], [19], [23], called also the Hill curve: 
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Notice that in the model used in this paper Ce = xe.  
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E0 denotes the baseline value (awake state - without drug), 
which by convention is typically assigned a value of 100, Emax 
denotes the maximum effect achieved by the drug infusion, 
EC50 is the drug concentration at 50% of the maximal effect 
and represents the patient sensitivity to the drug, and γ 
determines the steepness of the curve. 
The inverse of the Hill curve can be defined by the 
following formulation: 
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The type of models that consider a linear dynamic followed 
by a nonlinear dynamic system are called Wiener-
Hammarstein models and are presented in Fig. 2. These type 
of models have been widely used in control of anaesthesia 
[23]. For the automatic regulation of depth of anaesthesia 
(DOA) in Fig. 2 the anaesthetic agent, i.e. Propofol, is the 
input and the Bispectral Index (BIS) the output of the system. 
Because of its pharmacological profile, Propofol is applicable 
for both induction and maintenance of hypnosis during 
anaesthesia and intensive care sedation [24]. 
 
Fig. 2.  Schematic representation of the NONLINEAR SISO patient model 
for intravenous anaesthesia 
 
The Bispectral Index (BIS) is a signal that is derived from 
the electro-encephalogram (EEG) used to assess the level of 
consciousness in anaesthesia. A BIS value of 0 equals EEG 
silence,while a BIS value of 100 is the expected value of a 
fully conscious adult patient, 60-70 and 40-60 range represents 
light and moderate hypnotic conditions, respectively. The 
target value during surgery is 50, giving us a gap between 40 
and 60 to guarantee adequate sedation [1], [2], [3]. 
B. Advanced Model Based Control Strategies 
MPC is a control methodology based on two main 
principles: explicit on-line use of a process model to predict 
the process output at future time instants and the computation 
of an optimal control action by minimizing one or more cost 
functions, including constraints on the process variables. 
The main differences between the different types of MPC 
algorithms are: the type of model used to represent the process 
and its disturbances and the cost function(s) to be minimized, 
with or without constraints.  
1) EPSAC Strategy 
For the EPSAC approach, described in detail in [25], the 
controller output is obtained by minimizing the cost function: 
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The design parameters are: N1= the minimum costing horizon 
N2= the maximum costing horizon, N2-N1 = the prediction 
horizon Nu=control horizon,  =weight parameter, n(t) is the 
disturbance, y(t) the measured output and u(t) the model input. 
The signal r represents the reference trajectory.  
In our case the process input is represented by the Propofol 
infusion rate applied to the patient. The process output is 
predicted at time instant t over the prediction horizon N2-N1, 
based on the measurements available at that moment and the 
future outputs of the control signal. The cost function is an 
extended EPSAC cost function that penalizes the control 
movements using the weight parameter λ. 
2) Multi-Parametric Strategy 
Multi-parametric programming is a technique to solve an 
optimization problem, where the objective is to minimize or 
maximize a performance criterion subject to a given set of 
constraints where some of the parameters vary between 
specified lower and upper bounds. The main characteristic of 
mp-MPC is its ability to obtain: (i) the objective and 
optimization variable as a function of the varying parameters, 
and (ii) the regions in the space of the parameters where these 
functions are valid (critical regions) [26, 27] .This reduces the 
online implementation of the MPC to simple function 
evaluation, facilitating real time applications. 
For the mp-MPC, the generic optimization problem solved 
is: 
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where x are states, y outputs and u controls, all (discrete) time 
dependent vectors. The subsets of output variables that get 
tracked have time-dependent set points y
R. Finally Δu are 
changes in control variables, Δu(k) = u(k) – u(k-1). The 
prediction horizon is denoted by N and control horizon by Nu. 
X, U are the sets of the state and input constraints that contain 
the origin in their interior. Both  Q>0, the objective coefficient 
for the states and P>0, the terminal weight matrix for the 
states, are symmetric semi-positive definite matrices. The 
quadratic matrix for manipulated variables R>0 is a symmetric 
positive matrix, QR is the quadratic matrix for tracked outputs 
and R1 is a weight matrix for the control action changes (Δu). 
The control problem is posed as a quadratic convex 
optimization problem for which an explicit solution can be 
obtained as follows: 
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where s is the number of critical regions. 
C. Control Design 
The presence of the Hill nonlinearity complicates the use of 
linear controller synthesis. Two methods to overcome this 
problem have been proposed: exact and local linearization. 
Exact linearization is based on the compensation of the 
nonlinearity introduced by the Hill curve, in the PD model. 
Since the Hill nonlinearity (4) is a monotonic function (f) of 
the normalized effect site concentration, it has an inverse 
presented in (5). Using a parameter scheduling technique the 
inverse Hill function (f
-1
) could be implemented in the 
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controller as illustrated by the block diagram in Fig. 3. Here f 
is using the nonlinearity parameter of the real patient (E0 , 
Emax, EC50 , γ), while f
-1
 is using the parameter assumed by the 
controller (the nominal patient nonlinearity parameters a priori 
known  (E0
mean
, Emax
 mean
, EC50
 mean
 , γ mean). The controller aims 
at controlling the estimated drug concentration
eCˆ , which is 
straight-forward, using a linear controller. 
 
Fig. 3.  MPC control scheme 
An exact linearization occurs only in the case where the 
patient model is identical to the nominal model in which case 
it completely cancels the nonlinearity and 
ee CC 
ˆ . The local 
linearization is based on the linearized PK-PD model for a BIS 
value of 50 obtained using gPROMS [28] 
 
Fig. 4. Control scheme development flowchart  
An important challenges of DOA control is the high inter- 
and intra- patient variability. This results in different dynamics 
in PK model, and changes in the parameters of the Hill 
function for each patient model. Four control strategies, a 
model predictive controller, Extended Predictive Self 
Adaptive Controller (EPSAC), and three different multi-
parametric model predictive controllers (mp-MPC) are 
designed and evaluated. The framework for the different ways 
of designing the controllers is presented in Fig. 4. 
The patient response is simulated using Patient model 
block, composed of the PK-PD linear part (1) and the 
nonlinear PD part, the Hill nonlinearity (4). BIS can be 
measured, however the states cannot and have to be estimated: 
either using the drug rate and the nominal state space patient 
model, or by using the input and output measured output (BIS) 
of the process, the state space nominal model and a correction 
estimator based on the output changes.  
To analyse the influence of the changes in the dynamics of 
the PK model on the control performances, two types of 
control schemes are implemented, one uses the states given by 
the nominal model (B) and the other uses an estimator to 
adjust the states based on the dynamics of each patient (A).  
The influence to the changes of parameters of the Hill curve 
on the control performances is analysed by two types of 
control schemes, one using the local linearized PK-PD model 
(C) and the second is based on the exact linearization (D). The 
following design parameters are used: the objective 
coefficients for states (x), Q=0 when we have no state 
estimation and Q=1 in the case with state estimation, the 
quadratic matrix for tracked outputs (y), QR=1000, quadratic 
matrix for manipulated variables (u), R=1, the control horizon 
Nu=1 and the prediction horizon N=20 in both mp-MPC and 
EPSAC. The EPSAC has an extra weighting factor λ from (8) 
for which its default value λ=0 was used. The states used in 
the design of the controllers are x1, x2, x3, xe as described in 
(1). The clinically recommended sampling time is of 5 
seconds [6]. N1, N2 and Nu are chosen based on the 
characteristics of the process and the desired performances. 
Based on [29, 30] N should be large, at least 2n-1 but no larger 
than the rise-time of the process. For anaesthesia due to 
medical procedures we are constrained to use a small sampling 
time leads to a choice of a greater value for N. Also, the dead 
time is not considered since it’s very small and does not affect 
the process, therefore N1=1. In choosing Nu, for processes 
with no unstable/underdamped poles, like anaesthesia, Nu=1 is 
generally satisfactory. A choice of the Q, R and QR is given 
by Bryson’s rule [31]. 
1) Case 1: EPSAC 
In this section we apply a particular case of online MPC, the 
EPSAC (Extended Prediction Self-Adaptive Control) strategy 
described in detail in Section 2.3. The structure of the control 
system proposed in this section is shown in Fig. 5.  
 
Fig. 5. Case 1:  EPSAC control scheme 
The Patient block is composed of the PK and PD models. 
Control strategy based on nonlinearity compensation and I/O 
linear nominal patient model is used (Fig.4) The controller 
output is obtained by minimizing cost function (6) with the 
design parameters in section II.B.1 The control algorithm uses 
for prediction a transfer function derived from the PK-PD 
linear model (1). The inverse of the Hill curve (5) is used to 
compensate the nonlinearity. Both the linear model and the 
inverse of the Hill curve use the nominal values from Table 1. 
2) Case 2: mp-MPC without nonlinearity compensation 
The structure of the control scheme is presented in Fig.6. 
This approach uses the explicit/multi-parametric Model 
Predictive Control strategy based on local linearization of the 
PK-PD model and the state space model of the linearized 
nominal patient model (Fig.4). 
To obtain the linearized patient model we will first 
implement the PK and PD model for the nominal patient in 
gPROMS [28] and determine the state space of the linearized 
nominal patient model at BIS=50. Using these matrices the 
mp-QP optimization problem (7) is solved to obtain the 
critical regions CR, using a Matlab implementation of multi-
parametric quadratic programming algorithm [32] and 
determine the mp-MPC controller. 
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Fig. 6. Case 2: mp-MPC without nonlinearity compensation - control scheme  
3) Case 3: mp-MPC with nonlinearity compensation 
The explicit/multi-parametric Model Predictive Control is 
used again. Control strategy based on nonlinearity 
compensation and the state space model of the PK-PD linear 
part (1) for the nominal patient model is used (Fig.4). The PK-
PD model is no longer linearized as a whole in gPROMS like 
in the previous case (Case2). Instead, the PK-PD linear part 
(1), is implemented in Matlab and is used to obtain the state 
space of the nominal patient characteristics (A, B, C and D 
matrices). Having the state space obtained we solve the mp-
QP optimization problem (7), obtain the (CR) using POP [32] 
and determine the controller based on the nominal patient 
values. 
The inverse of the Hill curve (5) based on the nominal 
patient model parameters is then used to compensate the 
nonlinearity. Note that the states are obtained using the state 
space model based on the A, B, C and D matrices and the drug 
rate u as input. This control scheme is presented in Fig. 7. 
 
Fig. 7. Case 3:mp-MPC with nonlinearity compensation - control scheme  
4) Case 4: mp-MPC with nonlinearity compensation and 
estimation 
This approach also uses the explicit/multi-parametric Model 
Predictive Control strategy. The structure of this control 
scheme is similar to the one described in II.C.3. 
 
Fig. 8. Case 4: mp-MPC with nonlinearity compensation and estimator - 
control scheme 
The difference is that the State Space model nominal patient 
block from Fig.7 is replaced by a State Estimator. Here, the 
real patient states are estimated using a  Kalman filter [33] 
based on the state space of the nominal patient, the online BIS 
measurement and the drug rate. 
III. RESULTS 
In this section the results of a simulation study to evaluate 
the four control strategies, for the administration of Propofol 
are presented. DOA is monitored using the Bispectral Index 
(BIS) during the induction and maintenance phase of general 
anaesthesia. The closed loop control tests are performed on a 
set of 12 patients [14] plus an extra patient representing the 
nominal values of all 12 patients (PaN – patient nominal). The 
parameters values of these patients are given in Table 1 and 
are also used to calculate the parameters of the patient model.  
TABLE 1 
BIOMETRIC VALUES OF THE VIRTUAL PATIENTS 
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1 40 163 54 M 6.33 98.8 2.24 
2 36 163 50 M 6.76 98.6 4.29 
3 28 164 52 M 8.44 91.2 4.1 
4 50 163 83 M 6.44 95.9 2.18 
5 28 164 60 F 4.93 94.7 2.46 
6 43 163 59 M 12.0 90.2 2.42 
7 37 187 75 F 8.02 92.0 2.1 
8 38 174 80 M 6.56 95.5 4.12 
9 41 170 70 M 6.15 89.2 6.89 
10 37 167 58 M 13.7 83.1 1.65 
11 42 179 78 F 4.82 91.8 1.85 
12 34 172 58 M 4.95 96.2 1.84 
Mean  38 169 65 M 7.42 93.1 3 
 
All designed controllers are simulated first for the set of 
data presented in Table 1 in order to have a better 
understanding of their behaviour on the different types of 
patients, and analyse the inter- and intra- patient variability. 
Next, the four controllers will be tested against each other and 
simulated for different patients so as to be able to compare 
their performances by means of the BIS index and the 
corresponding Propofol infusion rates. 
A. Induction Phase 
Ideally the induction phase of the patient in an operational 
DOA is performed as fast as possible, such that little time is 
lost before the surgeon can start operating. It is therefore 
desirable that the patient reaches the BIS=50 target and 
remains within the target value without much undershoot or 
overshoot, i.e. values below BIS=40 and above BIS=60 should 
be avoided. In Fig.9, Fig. 11, Fig. 13, Fig. 14 we have the 
simulations of the four controllers for all 12 patients and the 
nominal one in the induction phase. Fig. 10 presents the map 
of the critical region for the controller using local linearization 
(Case 2) and in Fig. 12 we have the map of the critical regions 
for the controllers designed using exact linearization, by using 
the inverse of the Hill curve (Case 3 and 4). 
 
 
Fig.9. BIS output for all 13 patients for Case 1 
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Fig. 10. Map of critical regions Case 2 
 
Fig. 11. BIS output for all 13 patients for Case 2  
 
Fig. 12. Map of critical regions Case 3 and Case 4 
 
Fig. 13. BIS output for all 13 patients for Case 3 
 
Fig. 14. BIS output for all 13 patients for Case 4 
Simulations of some patients show very small oscillations 
around the steady state values. The average settling time for 
EPSAC is approximately 7 min and for the mp-MPC 
controllers is approximately 5 min. In common practice the 
operation procedure does not start until the patient reaches an 
adequate DOA, usually taking up to 15 min. Thus, a rise time 
between 5 min and 7 min gives good performances. 
 
Fig. 15. BIS response for the four controllers for PaN 
 
Fig. 16. Output for the four controllers for the PaN 
 
Fig. 17. BIS response for the four controllers for patient 9 
 
Fig. 18. Output for the four controllers for patient 9 
The best performances are obtained for Case 2. It seems that 
the local linearization is able to deal with inter- and intra- 
patient variability Also, the process was linearized at BIS=50 
which is the value of the controller set point. The EPSAC 
controller is more influenced by inter-patient variability and 
for some patients the settling time has greater values. 
The four controllers: EPSAC and the mp-MPC controllers, 
are simulated, compared for PaN and presented in Fig. 15. For 
patient 9, the most sensitive patient, this simulation is 
presented in Fig. 17. In Fig. 16 and Fig. 18 we have the 
corresponding Propofol infusion rates for the two patients. We 
can observe that due to the less aggressive behaviour of the 
EPSAC controller the output evolution will be smoother. In all 
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the cases, the Propofol infusion rates are limited to 10 mg/s 
due to pump restrictions. The same conclusions as for Fig 9-12 
are valid here. For both simulated patients the EPSAC 
controller has a slower response.  
B. Maintenance Phase 
During the maintenance phase, it is important that the 
controller rejects the disturbances occurred during surgery as 
fast as possible and bring the patient to the BIS target value. In 
this phase, typical disturbances can be applied additively to 
the output of the process to check the controller’s ability to 
reject them [22]. A standard stimulus profile is defined and is 
presented in Fig 17. Each interval denotes a specific event in 
the operation theatre. Stimulus A represents response to 
intubation; B a surgical incision that is followed by a period of 
no surgical stimulation (i.e. waiting for pathology result); C 
mimics an abrupt stimulus after a period of low level 
stimulation; D the onset of a continuous normal surgical 
stimulation; E, F, and G simulate short-lasting, larger 
stimulation within the surgical period; and H represents the 
withdrawal of stimulation during the closing period [34]. 
 
Fig. 19. The artificially generated disturbance signal 
 
Fig. 20. BIS response for the four controllers for PaN with disturbance 
 
Fig. 21. Output for the four controllers for PaN with disturbance 
 
Fig. 22. BIS response for the four controllers for patient 9 with disturbance 
 
Fig.23. Output for the four controllers for patient 9 with disturbance 
In Fig. 20 and Fig. 22 the performance of disturbance 
rejection of the four controllers for PaN and a more sensitive 
patient (patient 9) are shown. The figures present the most 
challenging part of the disturbance rejection test, namely B-C-
D-E. In Fig. 21 and Fig.23 we have the corresponding 
Propofol infusion rate for PaN and patient 9, limited between 
0 and 10 mg/s. The simulations are performed for the 
maintenance phase using the disturbance signal Fig. 19, 
between 60 minutes and 140. The simulations show only small 
differences between the controllers and thus comparable 
performances of all four controllers. For the second control 
scheme the behaviour of the controller is less aggressive, the 
response is slower but it also has the smallest values of the 
undershoot. 
IV. DISCUSSION 
The aim of this study is to evaluate the performance of a 
model based predictive control algorithm and model predictive 
multi-parametric control for automatic induction and control 
of depth of anaesthesia (DOA) during the induction and the 
maintenance phases.  
Some of the most important aspects of this application are 
the high inter- and intra- patient variability, variable time 
delays, dynamics dependent on the hypnotic agent, model 
analysis variability. These are just some of the issues that are 
dealt with when trying to control the DOA.  
In this paper the hypnotic agent Propofol is given as input 
and the output is described by the BIS, resulting in a SISO 
system. SISO patient models for control of most anesthetic 
drugs already exist in the literature and their parameters are 
estimated based on age, weight, gender and height.  
Four different types of controllers are designed and tested. 
The first controller is based on the online optimization EPSAC 
MPC technique. The other three controllers are based on the 
offline optimization mp-MPC: one uses the linearized patient 
model and the other two use the compensation of the nonlinear 
part of the patient model. The difference between the two 
control strategies using nonlinearity compensation is that for 
one of them the states are computed using the nominal patient 
model whereas the other one uses an online estimator.  
In order to address the issue of inter- and intra- patient 
variability, each of the four controllers are first tested for the 
whole set of patients presented in Table 1 for the induction 
and the maintenance phase. The maps of the critical regions 
for the mp-MPC are presented in Figures 10 and 12. One can 
observe that for the controllers using the nonlinearity 
compensation (exact linearization) there are less critical 
regions than for the controller using local linearization. This 
will make the controllers from Case 3 and 4 easier to 
implement on embedded devices. 
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In the induction phase, for Case 1, representing the online 
EPSAC controller, we have an average settling time of 390 
seconds. The undershoot of the most sensitive patient is of 
4.6%. As it can be observed from Fig. 11, Fig. 13 and Fig. 14, 
representing the BIS response of the mp-MPC controllers, the 
three cases have very similar settling time, lower than for the 
EPSAC strategy, an average of 270 seconds. For the 
undershoot evaluation the worst case scenario is considered, 
meaning the most sensitive patient. We obtain for the first 
controller (Case 2) an undershoot of 3.7%, for Case 3 an 
undershoot of 5.8% and for Case 4 5.78%. All undershoots are 
below 10% which represents the maximum limit. For the 
induction phase it can be said that all four controllers perform 
well each of them having their own advantages: i.e. lower 
settling time, smaller undershoot. 
The controllers are tested in the maintenance phase in order 
to see how well they can deal with disturbance rejection. In 
Fig. 20 and Fig. 22 we can observe the four controllers 
response to a disturbance signal that mimics the events that 
occur in an operation theatre for PaN and for patient 9. 
All four controllers are tested against each other for the 
induction and maintenance phase for two different patients. 
The first patient is PaN, and the second patient used for 
comparison, patient 9, represents the most sensitive patient. It 
is worth mentioning that the controllers are designed using the 
values of the nominal patient which means that for this patient 
we will have the best behaviour of the controllers. As it can be 
observed from Fig. 15, Fig. 16, Fig. 20 and Fig. 21, the BIS 
response and the output for PaN in the induction phase and the 
maintenance phase respectively, the three offline controllers 
have a very similar behaviour. All the controllers present no 
undershoot and a fast settling time. The EPSAC controller has 
a less aggressive behaviour, hence, a longer settling time 
compared to the mp-MPC controllers, but as can be observed 
in the maintenance phase it will have less undershoot. In Fig. 
17, Fig. 18, Fig. 22 and Fig.23 we have the BIS response and 
the output for patient 9 in the induction phase and the 
maintenance phase. This patient represents the worst case 
scenario since it is the most sensitive patient. As we can 
observe from the figures, all four controllers have good 
performances and their responses are very close to each other. 
However, the controller from Case 2 gives the best 
performances for this patient in the induction phase 
particularly; lower undershoot, 3.7% and faster settling time, 
300 seconds. This shows that the combination between the 
linearization method based on gPROMS and optimization 
methods based on mp-MPC gives good results even without 
the nonlinearity compensation.  
It is important to state that the mp-MPC controller designed 
using the linearized patient model is the simplest version of 
the four controllers since it doesn’t use an estimator and it 
avoids using the nonlinearity compensation which introduces 
additionally complexity in the DOA control. Moreover, it 
obtains the best performances which can be explained through 
the fact that the nonlinearity of the Hill curve is more intense 
at extreme values of the BIS index and weaker around the BIS 
value of 50 where the model was linearized and where the BIS 
target is set. If the induction phase and the maintenance phase 
are kept around the value of 50%, Case 2 will give very good 
performances. But if the disturbances take the process out of 
the 50% area we can observe that the performances are not as 
good as in the case of nonlinearity compensation. Case 2 does 
not provide good performances if the disturbances are 
substantial. Due to the Hill nonlinearity the real patient model 
has smaller gain at the extreme values of the control variable. 
In the case of substantial disturbances, the control variable 
goes to the extreme values and the controller has a slower 
response but also a lower undershoot/overshoot. 
Using nonlinearity compensation is a good alternative in 
this case. Moreover, the computations required for the 
nonlinearity compensation are rather straight forward (the 
inverse of the Hill curve), and there are no recursive 
computations that might lead to accumulation of errors. 
The estimator used for the mp-MPC with nonlinearity 
compensation can also be applied for the mp-MPC using local 
linearization. It was not used for this study because as it can be 
observed from the simulations the case with nonlinearity 
compensation is more meaningful in the presence of 
disturbance. 
The aim of the studies on control of anaesthesia is to be able 
to implement the controllers on embedded devices (see 
MOBILE project). These types of devices do not have the 
same computational power as the computers where 
simulations are performed in real time. This would make 
classical MPC more difficult to implement since matrix 
operations are harder to program on embedded devices. The 
mp programming algorithms derive the explicit mapping of 
the optimal control actions as a function of the current states 
resulting in the implementation of a simple look up table and 
simple function evaluations. This makes the mp-MPC 
controllers much easier to implement for the control of depth 
of anaesthesia. 
For each patient there will be a variable dose-response 
relationship. For the same reference value, the controller sends 
different drug rate and the blood and effect-site concentrations 
levels are different for each patient. The safety limit for 
Propofol blood concentration and effect-site concentration is 
fulfilled by maintaining the drug infusion rate below 10mg/s. 
It can be observed from Fig. 16, Fig. 18, Fig. 21, Fig.23 that 
the drug infusion rates are maintained below this limit.  
Note that the robustness of the performance is analyzed by 
having the controllers designed on a nominal model [6] and 
then tested on wide set of patient models parameters where the 
impact of parameter uncertainties were analyzed. Formal 
robust criteria can also be included [27] and this represents a 
topic of our ongoing research. 
V. CONCLUSION 
In this paper we design and evaluate four different 
controllers for the regulation of depth of anaesthesia during 
induction and maintenance phase. For the maintenance phase, 
a realistic disturbance signal was considered and applied. A 
simulation study is performed on a set of 12 virtually 
generated patients plus the mean patient. The performance of 
the four controllers is compared with each other for a sensitive 
patient and the nominal patient. 
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Some important aspects of this application are the high 
inter-patient variability and the presence of important 
disturbances during the maintenance phase. The results show a 
high-efficiency, optimal dosage and robustness of the model 
predictive control algorithm to induce and maintain the 
desired Bispectral Index reference while rejecting typical 
disturbances from surgery. The multi parametric model 
predictive control approach, which is an offline optimisation 
method, has similar performances with the online method and 
promising results. 
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